awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28082910-AD3E62F9-203D-4BD1-8333-D7D2DAA654D2
Q28082910-AD3E62F9-203D-4BD1-8333-D7D2DAA654D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082910-AD3E62F9-203D-4BD1-8333-D7D2DAA654D2
Trial Watch: Proteasomal inhibitors for anticancer therapy
P2860
Q28082910-AD3E62F9-203D-4BD1-8333-D7D2DAA654D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082910-AD3E62F9-203D-4BD1-8333-D7D2DAA654D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8686d274f70c35e55f90f930a4d6747f2a7ea863
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.